Important Safety Alerts

Important Safety Alerts

Medical Device Safety Alert: Cranial Perforators with Automatic Clutch Mechanism

29 Sep 2015

The United States Food and Drug Administration (FDA) has issued an alert to remind neurosurgeons about the techniques for the safe use of cranial perforators with an automatic clutch mechanism to reduce the risk that these devices will fail to disengage or stop drilling.

Most cranial perforators are designed to automatically stop drilling after penetrating the skull to prevent the tip from unintentionally drilling or "plunging" into the brain. However, this clutch mechanism may fail to disengage if proper use, patient considerations, and device selection are not followed in accordance with the manufacturer's instructions for use. The clinical consequences of cranial perforators failing to disengage can be serious.

From January 2005 through August 2015, FDA received over 300 medical device reports associated with the use of cranial perforators with an automatic clutch mechanism failing to disengage, resulting in over 200 injuries. These injury reports describe patient injuries including perforation of the brain's protective covering just beneath the skull (dura mater), bleeding (hemorrhage), brain contusion, cerebral tissue damage, and decreased function of the brain (neurological deficit). The outcomes from these injuries have included seizures, damage to the portion of the brain responsible for language (aphasia), delayed/prolonged hospital stays, and the need for additional procedures.

The FDA analysis of currently available data suggests that failure to disengage is not specific to any manufacturer or brand of devices. The risk of these devices failing to disengage can be mitigated through proper use, patient considerations, and device selection in accordance with the device's instructions for use. Failing to follow the manufacturer's instructions for use can lead to the device not performing as expected, potentially placing patients at risk.

The FDA gives the following recommendations for neurosurgeons:

For details, please refer to the FDA websites:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm464616.htm
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm464596.htm

Posted on 29 September 2015

Back